Smartphones and fitbits track cancer drug side effects in real-time
NCT ID NCT05370469
Summary
This study is testing a remote monitoring system to better track symptoms and side effects in lung cancer patients taking oral targeted therapy pills. Participants use a smartphone app, a Fitbit watch, and a smart pill bottle cap for up to 24 weeks. The goal is to see if this system works well and can help guide future tools to improve patients' quality of life by catching side effects early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EGFR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Virginia
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.